A composite scale applied to evaluate anxiety in schizophrenic patients (SAES)

European Archives of Psychiatry and Clinical Neuroscience

Volumn 264, Issue 2, 2014, Pages 171-178

  Llorca, Pierre Michel ^a   Lancon, Christophe ^b   Blanc, Olivier ^a   De Chazeron, Ingrid ^a   Samalin, Ludovic ^a   Caci, Hervé ^c   Lesturgeon, Jean Alexandre ^d   Bayle, Franck J ^e  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d CH Sainte Marie   (France)

^e Section of Radiology   (France)

Author keywords

Anxiety; Reliability; Scale; Schizophrenia; Validity

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL EVALUATION; CORRELATION COEFFICIENT; FACTORIAL ANALYSIS; FEMALE; HEALTH SURVEY; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOLOGICAL RATING SCALE; SCALE OF ANXIETY EVALUATION IN SCHIZOPHRENIA; SCHIZOPHRENIA; SCORING SYSTEM; YOUNG ADULT;

ADULT; ANXIETY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 84896732415     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-013-0416-1     Document Type: Article

References (48)

1. Achim AM, Maziade M, Raymond É et al (2011) How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 37:811-821
2. Bailly D, Viellard M, Duverger H et al (2003) Un diagnostic méconnu: la schizophrénie chez l'enfant. Ann Méd Psychol 161:652-659
3. Baylé FJ, Llorca PM, Olié JP et al (2000) Anxiété et schizophrénie: situation actuelle. Ann Méd Psychol 158:741-749
4. Llorca PM (2004) La schizophrénie. In: Leboyer M, Morselli PL (eds) Encyclopédie orphanet. Inserm, Paris
5. Bogren M, Mattisson C, Tambs K et al (2010) Predictors of psychosis: a 50-year follow-up of the Lundby population. Eur Arch Psychiatry Clin Neurosci 260:113-125
6. Muller N (2004) Mechanisms of relapse prevention in schizophrenia. Pharmacopsychiatry 37(Suppl. 2):S141-S147
7. Nuechterlein KH, Miklowitz DJ, Ventura J et al (2006) Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples. Psychiatry Res 144:153-166
8. Pallanti S, Quercioli L, Hollander E (2004) Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry 161:53-58
9. Picardi A, Rucci P, Girolamo G et al (2006) The quality of life of the mentally ill living in residential facilities. Eur Arch Psychiatry Clin Neurosci 256:372-381
10. Lecardeur L, Stip E, Giguere M et al (2009) Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: a randomized study. Schizophr Res 111:153-158
11. Steel C, Wykes T, Ruddle A et al (2010) Can we harness computerised cognitive bias modification to treat anxiety in schizophrenia? A first step highlighting the role of mental imagery. Psychiatry Res 178:451-455
12. Tsai J, Lysaker PH, Vohs JL (2010) Negative symptoms and concomitant attention deficits in schizophrenia: associations with prospective assessments of anxiety, social dysfunction, and avoidant coping. J Ment Health 19:184-192
13. Morrison JM, Myhr G (2010) Theory of mind and global empathy performance in schizophrenia: the role of anxiety, remission status and symptom type. Schizophr Res 117:327
14. Lysaker PH, Yanos PT, Outcalt J et al (2010) Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia. Clin Schizophr Relat Psychoses 4:41-48
15. Braga RJ, Petrides G, Figueira I (2004) Anxiety disorders in schizophrenia. Comp Psychiatry 45:460-468
16. Braga RJ, Mendlowicz MV, Marrocos RP et al (2005) Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J Psychiatric Res 39:409-414
17. Huppert JD, Smith TE (2001) Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor. J Nerv Ment Dis 189:669-675
18. Huppert JD, Weiss KA, Lim R et al (2001) Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr Res 51:171-180
19. Lysaker PH, Salvatore G, Grant MLA et al (2010) Deficits in theory of mind and social anxiety as independent paths to paranoid features in schizophrenia. Schizophr Res 124:81-85
20. Allilaire JF (1983) Angoisse psychotique et angoisse névrotique. Différence qualitative ou différence quantitative? L'Encéphale 9(suppl. 2):211B-216B
21. Cutler JL, Siris SG (1991) "Panic-like" symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: observations and implications. Comp Psychiatry 32:465-473
22. Baylé FJ, Blanc O, De Chazeron I et al (2011) Prise en charge médicamenteuse de l'anxiété chez le patient souffrant de schizophrénie. L'Encéphale 37(Supplement 1):S83-S89
23. Blin O, Azorin JM, Lecrubier Y et al (1989) Psychotic anxiety scale (PAS): évaluation de la fidélité intercotateurs et analyse factorielle des correspondances. L'Encéphale 15:543-547
24. Romain JL, Dermain P, Greslé P et al (1996) Efficacité de l'acétate de zuclopenthixol sur l'anxiété psychotique évaluée lors d'une étude ouverte. L'Encéphale 22:280-286
25. Blin O, Azorin JM, Bouhours P (1996) Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients. J Clin Psychopharmacol 16:38-44
26. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50-55
27. Tyrer P, Owen RT, Cicchetti DV (1984) The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale. J Neurol Neurosurg Psychiatry 47:970-975
28. Guy W, Ban TA (1982) The AMDP-System. Manual for the assessment and documentation of psychopathology. Springer, Berlin Heidelberg
29. Asberg M, Montgomery SA, Perris C et al (1978) A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica Suppl. 271:5-27
30. Guelfi JD, Waintraub L, Fermanian J et al (1987) La version française de la CPRS: analyse factorielle sur un échantillon de 208 patients. L'Encéphale 2:395-400
31. Pichot P, Pull CB, von Frenckell R et al. (1981) Une analyse factorielle de l'échelle d'appréciation de l'anxiété de Hamilton. Psychiat Fennica:183-189
32. Lesur A, Bonnet D, Vicaut E et al (1989) L'échelle brève d'anxiété de Tyrer en pratique extrahospitalière: première validation en langue française. L' Encéphale 15:535-542
33. Bobon D, von Frenckell R, Troisfontaines B et al (1985) Preliminary construction and validation of an anxiety scale derived from the French version of the AMDP, the AMDP-AT. Encephale 11:107-111
34. Likert R (1932) A technique for the measurement of attitudes. Archives Psychol 140:5-55
35. Bowles N (1999) The Delphi technique. Nurs Standard 13:32-36
36. Lançon C, Aghababian C, Llorca P-M BD, Auquier P (1999) An exploration of the psychometric properties of the French-language version of the positive and negative syndrome scale (PANSS). Can J Psychiatry 44:893-900
37. Kaiser HF (1974) An index of factorial simplicity. Psychometrika 39:31-36
38. Lance CEBM, Michels MC (2006) The sources of four commonly reported cutoff criteria, what did they really say? Organizational Res Meth 9:202-220
39. Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420-428
40. Kline P (1994) An easy guide to factor analysis. Routledge, London
41. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull 13:261-274
42. Huppert JD, Smith TE (2005) Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms. CNS Spectr 10:721-731
43. Peuskens J, Van Baelen B, De Smedt C et al (2000) Effects of risperidone on affective symptoms in patients with schizophrenia. Int Clin Psychopharmacol 15:343-349
44. Tollefson GD, Sanger TM, Lu Y et al (1998) Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Arch Gen Psychiatry 55:250-258
45. Kinon BJ, Ascher-Svanum H, Adams DH et al (2008) The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials. J Clin Psychopharmacol 28:544-549
46. Danion JM, Rein W, Fleurot O (1999) Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Am J Psychiatry 156:610-616
47. Dollfus S, Olivier V, Chabot B et al (2005) Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients. Schizophr Res 78:157-159
48. Kim SW, Shin IS, Kim JM et al (2007) Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 31:1504-1509